Company intelligence / Profile preview
Japan BCG Laboratory
Bunkyo-ku, Tokyo, Japanbcg.gr.jp ↗
- Ownership
- Private
- Employees
- ~60
- Development stage
- Other
01
Overview
Japan BCG Laboratory has been the sole supplier of the Bacillus Calmette–Guérin (BCG) vaccine in Japan since 1952 and has distributed over 2.25 billion doses globally. Its vaccines are WHO-prequalified and used both for tuberculosis prevention and as an immunotherapy for bladder cancer. The company’s products are approved and commercially available in multiple countries[1][4][5].
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- VaccineBiological products
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
UNICEFWorld Health Organization (WHO)Pan American Health Organization (PAHO)
Beyond the preview
Go deeper on Japan BCG Laboratory.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Japan BCG Laboratory.